tert-Butyl (1R*,4R*)-4-(4-fluoro-1-oxoisoindolin-2-yl)cyclohexylcarbamate, 1g

2-Fluoro-N-[2-(2-methyl-1H-indol-3-yl)ethyl]benzamide, 99%, 25mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 200, 6000 ml, 250 mm, 1 Piece

6'-(Pyridin-4-yl)-3,4':2',4''-terpyridine, 98%, 250mg

Cycloheptanol, 95.0%, 5g

3-iodo-2-methyl-1,4-dihydroquinolin-4-one, 98%, 250mg

1-(3-Bromo-phenyl)-1H-pyrrole, 95.0%, 10g

tert-Butyl ((1,2,4,5-tetrazin-3-yl)methyl)carbamate, 250mg

5-Bromo-2-fluoropyridine-3-boronic acid pinacol ester, 95.0%, 1g

1,4-Dibromo-2-nitrobenzene>98.0%(GC)250g

4-Bromo-1-methyl-3-(pyrrolidin-1-yl)-1h-pyrazole, 98%, 1g

Oxetan-3-ylmethanol, 95.0%, 100mg

1-Butyl-2,3,4,5,6,7-hexahydro-3-methyl-2,4,6-trioxo-1H-pyrrolo[2,3-d]pyrimidine-5-acetic acid, 97%, 100mg